De Novo device
Neurolutions Upper Extremity Rehabilitation System
Neurolutions, Inc. · Electroencephalography (Eeg)-Driven Upper Extremity Powered Exerciser (QOL, Class II) · First FDA decision Apr 23, 2021, newest Apr 23, 2021Stroke recovery and rehabilitation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
2
Naming "Neurolutions"
MAUDE reports
0
Brand "Neurolutions", since 2015
PubMed studies
0
Mentioning "Neurolutions"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Neurolutions Upper Extremity Rehabilitation SystemNew device typeBreakthroughDe Novo
DEN200046 · Decided Apr 23, 2021 · 274 days after receipt
Device type: Electroencephalography (Eeg)-Driven Upper Extremity Powered Exerciser (QOL) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Neurolutions", any status and sponsor, newest update first.
- Fully Remote Use of IpsiHand Device in Hemiparetic StrokePivotal-lookingCompleted
Neurolutions, Inc.Not on our public-company list
NCT05965713 · 109 participants · Start Oct 1, 2023 · Primary completion Sep 12, 2025
Device: Neurolutions IpsiHand Upper Extremity Rehabilitation System · For: Stroke; Hemiparesis; Spasticity as Sequela of Stroke and 2 more
Sites: St Louis, Missouri
- Prospective Real-World Evidence Study of the IpsiHand® System in Adult Stroke SurvivorsNot yet recruiting
Neurolutions, Inc.Not on our public-company list
NCT07147881 · 100 participants (planned) · Start Sep 1, 2025 · Primary completion Dec 1, 2027
Device: IpsiHand · For: Stroke; Hemiparesis After Stroke; Brain Computer Interface
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Neurolutions", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QOL
2 reports: 2 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Neurolutions"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.